How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market
Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the '90s. The post How Pfizer’s decision in the ’90s cost them a stronghold in...
View ArticleThe radiopharmaceutical revolution: From diagnosis to treatment, oncology and...
Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation. The post The radiopharmaceutical revolution: From diagnosis to...
View ArticleThe biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024. The post The biggest private biotech investments in September 2024 appeared...
View ArticleSpinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition. The post Spinal cord injury: Are we getting closer to a treatment?...
View ArticleTop biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month. The post Top biotech deals of September 2024 appeared...
View ArticlePromising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. The post Promising cure for COPD: Is a breakthrough treatment within...
View ArticleJAK inhibitors: Are they a good option for treating inflammatory diseases and...
Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer. The post JAK inhibitors: Are they a good option for treating inflammatory diseases...
View ArticleThe AI boom in cancer: Game-changer or just hype?
Is AI just hype or a game-changer? Delve into AI's contribution to oncology, from diagnostics to drug discovery and personalized treatment. The post The AI boom in cancer: Game-changer or just hype?...
View ArticleHow biotech startups are trying to save the oceans with lab-grown fish
Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products. The post How biotech startups are trying to save the oceans with...
View ArticleCould next-generation “switchable” CAR-T cells help improve the safety and...
Discover how next-generation "switchable" CAR-T cells could improve both the safety and efficacy of CAR-T therapies. The post Could next-generation “switchable” CAR-T cells help improve the safety and...
View ArticleSpatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? The post Spatial Transcriptomics: A...
View ArticleCan AI cure Alzheimer’s disease?
A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable...
View Article